Savanna Biotherapeutics

Aliso Viejo, CA · Founded 2020 · Privately Held (backing)

The company is currently operating in Stealth mode. Savanna Biotherapeutics is based in Aliso Viejo, CA and was founded in 2020. It was valued at $49 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $37.3 million across 1 recorded round; the latest was a $13 million early-stage round in Jun 2025.

PMV mark · valuation
$49.0M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$37.3M
Last round
Early Stage VC
Jun 2025
How much has Savanna Biotherapeutics raised?
$37.3Macross 1 recorded rounds · Jun 2025 – Jun 2025

Most recently, Savanna Biotherapeutics raised $13.0M in its Early Stage VC (Jun 2025).

Free account
More of Savanna Biotherapeutics with a free account
  • ·Watch Savanna Biotherapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Savanna Biotherapeutics round by round

1 rounds
Jun 2025Early Stage VC$13.0MSEC filing▮
30 investors participated

How much has Savanna Biotherapeutics raised?

Savanna Biotherapeutics has raised $37.3 million in total; 1 of its rounds is on record. The largest on record was a $13 million early-stage round in Jun 2025.

Savanna Biotherapeutics has filed 1 Form D with the SEC, most recently in Jun 2025 ($13 million sold to 30 investors).

Savanna Biotherapeutics investors

2 investors are on record for Savanna Biotherapeutics, including Medical Excellence Capital and National Institutes of Neurological Disorders and Stroke. The early-stage round in Jun 2025 drew 30 investors.

For fundraisers
Raising for a company like Savanna Biotherapeutics?

2 investors have backed Savanna Biotherapeutics.

See all 2 investors →

Frequently asked about Savanna Biotherapeutics

How much has Savanna Biotherapeutics raised?
Savanna Biotherapeutics has raised $37.3M in total across 1 recorded funding rounds.
When was Savanna Biotherapeutics's last funding round?
Savanna Biotherapeutics's most recent recorded round was Early Stage VC in Jun 2025, raising $13.0M.